Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360
android app
/
iOS App/ web portal.
{
"products": [
{
"_id": "6ad74702e53c888beeab308d",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliozin 10 mg, Sitagliptin 100 mg and Metformin hydrochloride 1000 mg ER Tablets",
"description": "GLIEMPAFLOZIN 3D 10 is a triple-combination antidiabetic tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This combination is intended for the management of type 2 diabetes mellitus in appropriately selected patients under the supervision of a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help regulate blood glucose levels. Empagliflozin helps the kidneys eliminate glucose through urine, Sitagliptin supports glucose-dependent insulin regulation, and Metformin helps reduce glucose production in the liver while improving insulin sensitivity.\n\nBy combining these ingredients in one tablet, GLIEMPAFLOZIN 3D 10 provides a multi-mechanism approach to blood glucose management. Its suitability depends on the patient's clinical condition, kidney function, existing treatment, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 10\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 10 mg: A sodium-glucose cotransporter 2 (SGLT2) inhibitor that reduces glucose reabsorption by the kidneys and increases glucose excretion through urine.\nSitagliptin 100 mg: A dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate insulin and glucagon responses according to blood glucose levels.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, approved indications, and administration instructions should be confirmed from the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 10 Tablets\nGLIEMPAFLOZIN 3D 10 combines three established antidiabetic medicines with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: Targets different processes involved in blood glucose regulation.\nExtended-release metformin: Provides a formulation designed to release Metformin gradually over time.\nOral tablet dosage form: Allows administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThe combination is not suitable for every person with diabetes. Treatment decisions should be based on individual medical needs and the approved product information.\n\nUses of GLIEMPAFLOZIN 3D 10\nGLIEMPAFLOZIN 3D 10 is intended for the management of type 2 diabetes mellitus, subject to its approved indications and the prescribing healthcare professional's assessment.\n\nType 2 diabetes is a chronic metabolic condition characterized by impaired insulin action and, in many patients, insufficient insulin production. Persistently elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three active ingredients in GLIEMPAFLOZIN 3D 10 address different aspects of glucose regulation. A healthcare professional may consider this combination when multiple medicines are required to achieve an individual's treatment goals and when the combination is clinically appropriate.\n\nThe medicine should be used as part of a comprehensive diabetes-management plan that may include balanced nutrition, regular physical activity, blood glucose monitoring, and routine medical assessments. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 10 Work?\n1. Empagliflozin 10 mg\nEmpagliflozin belongs to the SGLT2 inhibitor class. It blocks a protein responsible for reabsorbing glucose filtered by the kidneys. This allows more glucose to be eliminated through urine, helping reduce blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. Whether these benefits apply to an individual depends on their clinical condition and the applicable prescribing information.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. By increasing incretin activity, Sitagliptin supports insulin release when blood glucose is elevated and helps regulate glucagon secretion. These actions contribute to blood glucose control.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily reduces glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nTogether, these ingredients target several pathways involved in type 2 diabetes. Their combined effectiveness and safety depend on appropriate prescribing, correct administration, and regular monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 10\nWhen prescribed for an appropriate patient, GLIEMPAFLOZIN 3D 10 may offer the following treatment advantages:\n\nMultiple mechanisms of action: Combines three medicines that influence different aspects of glucose regulation.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nCombination therapy: May simplify a treatment regimen compared with taking the same ingredients as separate tablets.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nPersonalized treatment options: May be considered when a healthcare professional determines that triple therapy is appropriate.\nIndividual outcomes vary, and the medicine does not replace a suitable diet, physical activity, or routine diabetes care.\n\nDirections for Use\nTake GLIEMPAFLOZIN 3D 10 only as prescribed by your healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or your prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or stop treatment without consulting your prescriber.\nAttend recommended appointments for kidney-function assessment and blood glucose monitoring.\nIf you miss a dose, follow the official patient information or ask your healthcare professional or pharmacist what to do. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 10 is a prescription medicine and may not be suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important kidney-related prescribing considerations.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients at risk of dehydration or low blood pressure should discuss appropriate precautions with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin may increase the risk of genital fungal infections and can be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, or excessive alcohol intake.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nHypoglycemia: Low blood glucose may occur, particularly when the combination is used with insulin or insulin secretagogues such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, and upcoming procedures involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 10?\nGLIEMPAFLOZIN 3D 10 brings together Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg in a triple-combination tablet intended for selected patients with type 2 diabetes.\n\nFor pharmaceutical websites, pharmacies, distributors, and healthcare professionals, clear information about composition, mechanism of action, potential uses, and precautions supports responsible product awareness.\n\nAlways refer to the approved product label for the exact composition, indications, dosage, contraindications, storage requirements, and instructions for use.\n\nConclusion\nGLIEMPAFLOZIN 3D 10 Tablets combine Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. The combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 10?\n\nGLIEMPAFLOZIN 3D 10 is a combination tablet containing Empagliflozin 10 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 10 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom this combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 10 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 10 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 10 suitable for everyone with diabetes?\n\nNo. Suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and approved prescribing information.\n\n",
"price": 210.0,
"discountamount": 147.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2505,
"imageuri": "https://productimages.withfloats.com/actual/6ad7470422551901df6e5493.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7470422551901df6e5493.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:48:34.116Z",
"updatedon": "2026-10-20T10:48:34.116Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM/products/empagliozin-10-mg-sitagliptin-100-mg-and-metformin-hydrochloride-1000-mg-er-tablets/2505",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 10",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad7442bf24c5a4bbccf4b10",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Empagliflozin,Sitagliptin And Metformin Hydrochloride (ER) Tablets",
"description": "GLIEMPAFLOZIN 3D 25 is a combination pharmaceutical product containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride Extended Release (ER) 1000 mg. This triple-combination formulation is intended for the management of type 2 diabetes mellitus in appropriate patients, as determined by a qualified healthcare professional.\n\nThe three active ingredients work through different mechanisms to help control blood glucose levels. Empagliflozin belongs to the sodium-glucose cotransporter 2 (SGLT2) inhibitor class, Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin is a biguanide antidiabetic medicine. Together, these ingredients target different pathways involved in glucose regulation.\n\nGLIEMPAFLOZIN 3D 25 provides a combination of three established antidiabetic agents in a single tablet. Its suitability depends on the patient's blood glucose levels, kidney function, current diabetes treatment, medical history, and the approved prescribing information.\n\nComposition of GLIEMPAFLOZIN 3D 25\nEach tablet contains the following stated active ingredients:\n\nEmpagliflozin 25 mg: An SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine.\nSitagliptin 100 mg: A DPP-4 inhibitor that increases the activity of incretin hormones involved in glucose-dependent insulin release and glucagon regulation.\nMetformin Hydrochloride ER 1000 mg: An extended-release biguanide that primarily reduces glucose production in the liver and improves the body's response to insulin.\nThe exact formulation, excipients, administration instructions, and approved indications should be verified against the product packaging and official prescribing information.\n\nKey Features of GLIEMPAFLOZIN 3D 25\nGLIEMPAFLOZIN 3D 25 combines three antidiabetic ingredients with complementary mechanisms of action.\n\nTriple-combination formulation: Contains Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER.\nMultiple glucose-control pathways: The ingredients act through different mechanisms involved in blood glucose regulation.\nExtended-release metformin: The ER formulation is designed to release metformin over an extended period.\nOral tablet dosage form: Provides oral administration according to the prescribed regimen.\nIndividualized diabetes management: May be considered by a healthcare professional when combination therapy is appropriate.\nThe benefits of this combination depend on the patient's clinical needs and the suitability of all three ingredients.\n\nUses of GLIEMPAFLOZIN 3D 25 Tablets\nGLIEMPAFLOZIN 3D 25 is intended for the management of type 2 diabetes mellitus, subject to the product's approved indications and the prescribing healthcare professional's judgment.\n\nType 2 diabetes is a chronic metabolic condition in which the body does not use insulin effectively or does not produce enough insulin to maintain healthy blood glucose levels. Long-term elevated blood glucose can increase the risk of complications affecting the eyes, kidneys, nerves, heart, and blood vessels.\n\nThe three medicines in GLIEMPAFLOZIN 3D 25 target different aspects of glucose regulation. A healthcare professional may consider a combination regimen when an individual's treatment goals are not adequately achieved with a simpler regimen or when the combination is otherwise clinically appropriate.\n\nThe medicine should be used alongside an individualized diabetes-management plan that may include a balanced diet, physical activity, glucose monitoring, and regular medical follow-up. It is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.\n\nHow Does GLIEMPAFLOZIN 3D 25 Work?\nThe three active ingredients contribute to blood glucose management through distinct mechanisms.\n\n1. Empagliflozin 25 mg\nEmpagliflozin inhibits SGLT2, a protein responsible for reabsorbing much of the glucose filtered by the kidneys. By reducing glucose reabsorption, it increases glucose excretion through urine and helps lower blood glucose levels.\n\nEmpagliflozin has also demonstrated cardiovascular and kidney benefits in certain eligible patient populations. These benefits depend on the patient's condition and the applicable prescribing information and should not be assumed to apply identically to every patient.\n\n2. Sitagliptin 100 mg\nSitagliptin inhibits the DPP-4 enzyme, which breaks down incretin hormones. Increasing incretin activity helps stimulate insulin release when blood glucose is elevated and reduces glucagon secretion when appropriate. This helps regulate glucose levels, particularly after meals.\n\n3. Metformin Hydrochloride ER 1000 mg\nMetformin primarily decreases glucose production in the liver and improves insulin sensitivity. The extended-release formulation is designed to release the medicine gradually over time.\n\nBy combining these mechanisms, GLIEMPAFLOZIN 3D 25 targets several pathways involved in type 2 diabetes. Its overall effectiveness and safety depend on appropriate patient selection, dosing, and ongoing monitoring.\n\nPotential Benefits of GLIEMPAFLOZIN 3D 25\nWhen prescribed for an appropriate patient, this combination may offer the following treatment advantages:\n\nMultiple mechanisms of action: Addresses glucose regulation through three different pharmacological pathways.\nBlood glucose management: Helps improve glycemic control in eligible adults with type 2 diabetes.\nOral combination therapy: Combines three medicines in one tablet, which may simplify a prescribed regimen compared with taking each ingredient separately.\nExtended-release component: Includes Metformin Hydrochloride ER for gradual drug release.\nIndividualized treatment options: May be considered when a healthcare professional determines that all three ingredients are appropriate.\nThese potential advantages do not guarantee a particular result. Treatment effectiveness depends on adherence, diet, physical activity, individual health status, and medical supervision.\n\nDirections for Use\nGLIEMPAFLOZIN 3D 25 should be taken only as prescribed by a qualified healthcare professional.\n\nFollow the prescribed dose and administration schedule.\nTake the tablet with food if directed by the product labeling or prescriber.\nSwallow the extended-release tablet whole unless the specific product instructions state otherwise. Do not crush, chew, or split it without professional guidance.\nDo not change the dose or discontinue treatment without consulting your prescriber.\nAttend recommended appointments for blood glucose monitoring and kidney-function assessment.\nIf a dose is missed, follow the official patient information or ask your healthcare professional or pharmacist for advice. Do not take an extra dose to compensate for a missed dose unless specifically instructed.\n\nPrecautions and Safety Information\nGLIEMPAFLOZIN 3D 25 is a prescription medicine and is not suitable for everyone.\n\nKidney function: Kidney function should be assessed before and during treatment as appropriate. Metformin and Empagliflozin have important renal considerations, and the combination may be unsuitable at certain levels of kidney impairment.\n\nDehydration: Empagliflozin increases glucose excretion through urine and may increase urination. Patients should discuss dehydration risk, low blood pressure, and fluid intake with their healthcare professional.\n\nGenital and urinary infections: Empagliflozin can increase the risk of genital fungal infections and may be associated with urinary tract infections.\n\nLactic acidosis: Metformin can rarely cause a serious condition called lactic acidosis. Risk may increase with significant kidney impairment, severe dehydration, certain acute illnesses, excessive alcohol intake, or other predisposing conditions.\n\nPancreatitis: Pancreatitis has been reported in patients taking Sitagliptin. Severe, persistent abdominal pain requires prompt medical assessment.\n\nLow blood glucose: The risk of hypoglycemia may increase when this combination is used with insulin or insulin secretagogues, such as sulfonylureas.\n\nInform your healthcare professional about existing medical conditions, all medicines you take, pregnancy or breastfeeding, planned surgery, prolonged fasting, or an upcoming medical procedure involving iodinated contrast. Follow professional instructions about temporary medicine interruption during acute illness or other high-risk situations.\n\nSeek urgent medical care for severe abdominal pain, difficulty breathing, unusual weakness, persistent vomiting, severe dehydration, or other serious symptoms.\n\nWhy Choose GLIEMPAFLOZIN 3D 25?\nGLIEMPAFLOZIN 3D 25 brings together Empagliflozin, Sitagliptin, and Metformin Hydrochloride ER in a triple-combination tablet designed for the management of type 2 diabetes in appropriately selected patients.\n\nFor pharmaceutical product catalogues, distributors, pharmacies, and healthcare professionals, accurate information about the composition, mechanism of action, approved indications, and safety profile supports responsible product awareness.\n\nTreatment decisions should always be based on the patient's medical assessment and the approved product information.\n\nConclusion\nGLIEMPAFLOZIN 3D 25 Tablets combine Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg to target multiple pathways involved in blood glucose regulation. This combination may be appropriate for selected adults with type 2 diabetes under medical supervision.\n\nFor complete information about dosage, contraindications, warnings, storage, and approved indications, consult the official product packaging and prescribing information. Use this medicine only under the direction of a qualified healthcare professional.\n\nFrequently Asked Questions (FAQs)\n1. What is GLIEMPAFLOZIN 3D 25?\n\nGLIEMPAFLOZIN 3D 25 is a combination tablet containing Empagliflozin 25 mg, Sitagliptin 100 mg, and Metformin Hydrochloride ER 1000 mg.\n\n2. What is GLIEMPAFLOZIN 3D 25 used for?\n\nIt is intended for the management of type 2 diabetes mellitus in patients for whom the combination is considered appropriate by a healthcare professional.\n\n3. How does GLIEMPAFLOZIN 3D 25 work?\n\nEmpagliflozin increases urinary glucose excretion, Sitagliptin supports glucose-dependent insulin regulation, and Metformin reduces glucose production in the liver and improves insulin sensitivity.\n\n4. Can GLIEMPAFLOZIN 3D 25 replace diet and exercise?\n\nNo. Medication should be combined with an individualized diet, physical activity, and monitoring plan as recommended by a healthcare professional.\n\n5. Is GLIEMPAFLOZIN 3D 25 suitable for everyone with diabetes?\n\nNo. Its suitability depends on the type of diabetes, kidney function, other medical conditions, concurrent medicines, and the approved prescribing information.",
"price": 230.0,
"discountamount": 69.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2504,
"imageuri": "https://productimages.withfloats.com/actual/6ad7442d6e565c5fe6e5b7cb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad7442d6e565c5fe6e5b7cb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:36:27.325Z",
"updatedon": "2026-10-20T10:36:27.325Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//empagliflozin-sitagliptin-and-metformin-hydrochloride-er-tablets/2504",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "GLIEMPAFLOZIN 3D 25",
"category": "DIABETIC RANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad73c502f1fbe0284e2dcb5",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Ketorolac Tromethamine Ophthalmic Solution",
"description": "CIPVISION KEYPROFEN 0.5 is an ophthalmic formulation containing Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory drug (NSAID) used in specific eye-care situations. It works by reducing the production of prostaglandins, chemical substances that contribute to pain and inflammation. This action may help manage certain inflammatory eye symptoms when the medicine is prescribed for an appropriate condition.\n\nCIPVISION KEYPROFEN 0.5 is intended for topical application to the eyes under the supervision of a qualified healthcare professional. Its suitability depends on the patient's symptoms, clinical diagnosis, and the approved product information.\n\nFor pharmacies, medical distributors, healthcare professionals, and pharmaceutical product catalogues, CIPVISION KEYPROFEN 0.5 represents an ophthalmic product containing a recognised anti-inflammatory ingredient. Appropriate product information helps users understand its intended role, administration requirements, and important precautions.\nComposition of CIPVISION KEYPROFEN 0.5\nThe stated active ingredient in CIPVISION KEYPROFEN 0.5 is:\n\nKetorolac Tromethamine 0.5% w/v: This medicine belongs to the NSAID class. It inhibits cyclooxygenase enzymes involved in the production of prostaglandins, helping reduce inflammatory activity and associated discomfort in suitable ophthalmic conditions.\n\nThe complete formulation, inactive ingredients, pack size, and approved therapeutic indications should be verified using the product packaging and official prescribing information.\nKey Features of CIPVISION KEYPROFEN 0.5 Eye Drops\nCIPVISION KEYPROFEN 0.5 has several important characteristics relevant to ophthalmic care:\n- NSAID-based formulation: Contains Ketorolac Tromethamine, a non-steroidal anti-inflammatory medicine.\n- Inflammation control: Helps manage inflammation in specific eye conditions when prescribed appropriately.\n- Prostaglandin reduction: Acts by inhibiting enzymes involved in the formation of inflammatory mediators.\n- Topical eye application: Designed for administration directly into the eye according to prescribed directions.\n- Clinically guided use: Requires an appropriate diagnosis and advice from an eye-care professional.\nThe potential role of this medicine depends on the underlying eye condition, the approved product indications, and the patient's individual health requirements.\nWhat Is CIPVISION KEYPROFEN 0.5 Used For?\nCIPVISION KEYPROFEN 0.5 may be prescribed for selected eye conditions in which reducing inflammation, itching, or pain is clinically appropriate. The precise indication should be confirmed from the approved product information.\n1. Management of Selected Inflammatory Eye Conditions\nInflammation of the eye may cause redness, irritation, watering, and discomfort. Ketorolac Tromethamine reduces the production of prostaglandins involved in the inflammatory response. An ophthalmologist can determine whether this medicine is suitable after assessing the cause of the symptoms.\n2. Relief of Certain Types of Eye Discomfort\nKetorolac Tromethamine ophthalmic preparations may help relieve ocular pain in approved clinical situations. Some formulations are also indicated for itching associated with seasonal allergic conjunctivitis. These uses depend on the specific product's approved labelling.\n\nPersistent eye pain, redness, or irritation should not be treated through self-medication because these symptoms can arise from infections, injuries, or other conditions requiring different treatment.\n3. Eye Care Following Certain Surgical Procedures\nSome Ketorolac Tromethamine ophthalmic products are used to manage pain and inflammation associated with eye surgery, including cataract procedures. Postoperative treatment must follow the ophthalmologist's instructions because the appropriate medicine, dosage, and duration depend on the procedure and the patient's recovery.\n\nAlways verify whether CIPVISION KEYPROFEN 0.5 is approved for the intended postoperative use before including a specific surgical indication in product information.\nHow Does CIPVISION KEYPROFEN 0.5 Work?\nKetorolac Tromethamine belongs to the non-steroidal anti-inflammatory drug category. Its action involves inhibiting cyclooxygenase (COX) enzymes, which help produce prostaglandins.\n\nProstaglandins participate in inflammatory processes and pain signalling. By reducing their production, Ketorolac Tromethamine can help control inflammation and associated discomfort in certain eye conditions.\n\nUnlike corticosteroids, Ketorolac Tromethamine is a non-steroidal anti-inflammatory medicine. However, it is not appropriate for every eye complaint. It does not treat all causes of eye redness or pain, and suspected infections may require a different treatment approach.\nPotential Benefits of CIPVISION KEYPROFEN 0.5\nWhen prescribed for an appropriate indication, CIPVISION KEYPROFEN 0.5 may offer the following benefits:\n- Anti-inflammatory action: Helps reduce inflammatory activity in selected ophthalmic conditions.\n- Management of eye pain: May relieve pain in specific clinical situations covered by the relevant product indication.\n- Non-steroidal treatment option: Provides an alternative mechanism to corticosteroid-based medicines for appropriate cases.\n- Local administration: Allows the active ingredient to be delivered directly to the eye.\n- Support for ophthalmic treatment: May be included in a treatment plan developed by an eye-care professional.\nThe response to treatment varies according to the diagnosis, severity of the condition, individual health factors, and adherence to the prescribed instructions. The product should not be considered a universal treatment for eye pain or inflammation.\nHow to Use CIPVISION KEYPROFEN 0.5 Eye Drops\nUse CIPVISION KEYPROFEN 0.5 only according to your ophthalmologist's instructions and the product leaflet.\n1. Clean your hands: Wash and dry your hands before handling the eye-drop bottle.\n2. Check the bottle: Confirm the product name, expiry date, and administration instructions before use.\n3. Prevent contamination: Keep the dropper tip away from your eyes, eyelids, fingers, and other surfaces.\n4. Follow the prescribed dosage: Use only the recommended number of drops and the prescribed frequency.\n5. Use other eye medicines carefully: Ask your healthcare professional how much time to leave between different ophthalmic preparations.\n6. Avoid prolonged use: Do not continue treatment longer than recommended, as extended NSAID use may increase the risk of eye complications.\n7. Follow storage instructions: Store the medicine as directed on its packaging and observe any instructions concerning use after opening.\n8. Do not share the bottle: Sharing eye drops can increase the risk of contamination.\n9. Attend follow-up appointments: Follow your ophthalmologist's advice, particularly when using the medicine after eye surgery.\nIf you miss a dose, follow the instructions in the product leaflet or consult your healthcare professional. Do not double the next dose to compensate for a missed application.\nPrecautions and Safety Information\nAlthough Ketorolac Tromethamine eye drops can be useful in appropriate clinical settings, they may cause side effects and require additional caution in certain patients.\nPossible Side Effects\nSome people may experience temporary burning, stinging, irritation, or discomfort after applying the drops. Ophthalmic NSAIDs can also delay healing and, in susceptible individuals, increase the risk of corneal complications. Rare cases of serious corneal damage have been reported.\n\nContact your ophthalmologist if symptoms persist or worsen. Seek urgent medical assessment if you experience severe eye pain, significant changes in vision, marked redness, or other serious symptoms.\nImportant Precautions\n- Corneal conditions: Tell your doctor if you have corneal disease, a damaged eye surface, or delayed healing.\n- Dry eyes: Inform your healthcare professional if you have severe dry eye symptoms or another condition affecting the eye surface.\n- Allergies: Disclose any previous allergic reaction to Ketorolac, aspirin, or other NSAIDs.\n- Bleeding risks: Discuss any bleeding disorder or medicine that may increase bleeding risk.\n- Eye surgery: Follow your surgeon's instructions, as postoperative use requires appropriate monitoring.\n- Pregnancy and breastfeeding: Consult your doctor before using the medicine during pregnancy or while breastfeeding.\n- Other medicines: Inform your healthcare professional about all medicines and eye preparations you currently use.\nCIPVISION KEYPROFEN 0.5 is intended for ophthalmic use only. Keep it out of children's reach and never use it beyond the labelled expiry date.\nWhy Consider CIPVISION KEYPROFEN 0.5 for Pharmaceutical Product Portfolios?\nCIPVISION KEYPROFEN 0.5 combines a distinct pharmaceutical brand identity with Ketorolac Tromethamine 0.5% ophthalmic solution. The formulation may be relevant to product catalogues serving pharmacies, medical distributors, and healthcare professionals involved in ophthalmic care.\n\nClear product information supports responsible pharmaceutical communication by explaining the active ingredient, its mechanism of action, appropriate clinical applications, and safety considerations.\n\nFor accurate product representation, always verify the approved strength, indications, contraindications, dosage, storage requirements, and instructions against the official packaging and prescribing information.\nConclusion\nCIPVISION KEYPROFEN 0.5 Eye Drops contains Ketorolac Tromethamine 0.5% w/v, a non-steroidal anti-inflammatory ingredient used in selected ophthalmic conditions. By inhibiting prostaglandin production, it helps manage inflammation and may relieve pain in specific approved clinical settings.\n\nCorrect administration, appropriate patient selection, and awareness of potential side effects are essential for responsible use. Consult a qualified eye-care professional for treatment guidance and refer to the approved product information for complete details.\nFrequently Asked Questions (FAQs)\n1. What is CIPVISION KEYPROFEN 0.5?\nCIPVISION KEYPROFEN 0.5 is an ophthalmic solution containing Ketorolac Tromethamine 0.5% w/v, according to the composition provided. It is intended for specific eye-care applications under professional guidance.\n2. What is CIPVISION KEYPROFEN 0.5 used for?\nKetorolac Tromethamine ophthalmic preparations may be prescribed for certain inflammatory eye conditions, itching associated with seasonal allergic conjunctivitis, or pain and inflammation following specific eye procedures. The approved uses of CIPVISION KEYPROFEN 0.5 must be confirmed from its official product information.\n3. How does Ketorolac Tromethamine work in the eyes?\nKetorolac Tromethamine inhibits cyclooxygenase enzymes involved in prostaglandin production. This helps reduce inflammatory activity and associated pain in appropriate ophthalmic conditions.\n4. Can CIPVISION KEYPROFEN 0.5 be used without a prescription?\nUse this medicine only under appropriate medical guidance. An eye-care professional should determine whether it is suitable, particularly because NSAID eye drops can affect healing and may cause complications in susceptible patients.\n5. What precautions should be taken while using CIPVISION KEYPROFEN 0.5?\nAvoid contaminating the dropper tip, follow the prescribed dosage, and do not use the drops for longer than recommended. Inform your doctor about corneal problems, allergies to NSAIDs, bleeding disorders, and other medicines you use.\n6. How should CIPVISION KEYPROFEN 0.5 be stored?\nFollow the storage instructions on the product packaging. Keep the container closed as directed, protect it from unsuitable storage conditions, and observe any instructions concerning disposal after opening.\n\n\n",
"price": 80.0,
"discountamount": 56.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2503,
"imageuri": "https://productimages.withfloats.com/actual/6ad73c52dc6a6c6c9945f376.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad73c52dc6a6c6c9945f376.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T10:02:56.893Z",
"updatedon": "2026-10-20T10:02:56.893Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//ketorolac-tromethamine-ophthalmic-solution/2503",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION KEYPROFEN 0.5",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6ad738866e5950566f21f588",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Ofloxacin & Dexamethasoneone Sodium Phosphate Eye/Ear Drops",
"description": "CIPVISION ONLYAX DEXA Eye/Ear Drops is a pharmaceutical formulation containing Ofloxacin and Dexamethasone Sodium Phosphate. These ingredients perform complementary roles: Ofloxacin helps control infections caused by susceptible bacteria, while Dexamethasone Sodium Phosphate helps reduce inflammation. The combination may be prescribed for selected eye or ear conditions when both antibacterial treatment and inflammation control are clinically appropriate.\n\nIntended for ophthalmic and otic applications, CIPVISION ONLYAX DEXA should be used according to a qualified healthcare professional's instructions. The suitability of this formulation depends on the patient's diagnosis, medical history, and the approved product information.\n\nWith its defined composition and distinct brand identity, CIPVISION ONLYAX DEXA is a pharmaceutical product option for healthcare professionals, pharmacies, and medical distributors.\n\nComposition of CIPVISION ONLYAX DEXA Eye/Ear Drops\n\nCIPVISION ONLYAX DEXA contains two active pharmaceutical ingredients:\n\nOfloxacin: A fluoroquinolone antibiotic that works by interfering with bacterial enzymes required for DNA replication and repair. This action helps inhibit the growth of susceptible bacteria.\n\nDexamethasone Sodium Phosphate: A corticosteroid that suppresses inflammatory responses and helps reduce symptoms such as redness, swelling, and discomfort when steroid treatment is appropriate.\n\nThe exact strength, approved indications, and recommended dosage should always be checked on the product packaging and prescribing information.\n\nKey Features of CIPVISION ONLYAX DEXA\n\nThe formulation combines antibacterial and anti-inflammatory properties in one topical product.\n\nDual-ingredient formulation: Combines an antibiotic with a corticosteroid.\n\nAntibacterial action: Ofloxacin targets susceptible bacteria when used for an appropriate indication.\n\nInflammation control: Dexamethasone Sodium Phosphate helps manage inflammatory symptoms.\n\nTopical application: Intended for eye or ear use according to the approved product labelling.\n\nProfessional supervision: Requires appropriate clinical assessment and guidance for safe use.\n\nThe suitability of these features depends on the diagnosed condition and whether both ingredients are necessary for treatment.\n\nWhat Is CIPVISION ONLYAX DEXA Used For?\n\nCIPVISION ONLYAX DEXA may be prescribed for certain bacterial eye or ear conditions accompanied by inflammation. A healthcare professional must determine whether this combination is appropriate for the specific diagnosis.\n\nOphthalmic Applications\n\nWhen indicated by the approved product label, an Ofloxacin and Dexamethasone formulation may be used for selected bacterial eye conditions associated with inflammation.\n\nOfloxacin helps address susceptible bacterial pathogens, while Dexamethasone Sodium Phosphate helps control the inflammatory response. However, eye redness, watering, itching, and pain can result from allergies, viral infections, fungal infections, or other disorders. These conditions may require different treatments.\n\nA proper eye examination is important before using antibiotic-corticosteroid drops.\n\nOtic Applications\n\nFor selected ear conditions, an appropriate antibiotic and corticosteroid combination may be prescribed when bacterial infection and inflammation occur together.\n\nSymptoms such as ear pain, discharge, swelling, and itching can have different causes. The choice of treatment depends on the site of infection, the condition of the eardrum, and the product's approved indications.\n\nUse CIPVISION ONLYAX DEXA in the ear only when the prescribing information permits it and a healthcare professional recommends its use.\n\nHow Does CIPVISION ONLYAX DEXA Work?\n\nThe two active ingredients act through different mechanisms.\n\nOfloxacin: This antibiotic inhibits bacterial enzymes called DNA gyrase and topoisomerase IV. These enzymes are essential for bacterial DNA replication and repair. Interfering with these processes helps prevent susceptible bacteria from multiplying.\n\nDexamethasone Sodium Phosphate: This corticosteroid reduces inflammatory activity in affected tissues. It helps control inflammation and associated symptoms when corticosteroid treatment is medically appropriate.\n\nTogether, these ingredients provide antibacterial and anti-inflammatory effects in selected conditions. However, corticosteroids may mask signs of infection or worsen certain untreated infections. Therefore, this combination should only be used for an appropriate diagnosis under medical supervision.\n\nPotential Benefits of CIPVISION ONLYAX DEXA\n\nThe potential benefits depend on the patient's condition and the clinical suitability of the formulation.\n\nCombined treatment approach: Offers an antibiotic and an anti-inflammatory ingredient in one formulation.\n\nTargeted antibacterial activity: Ofloxacin acts against susceptible bacteria.\n\nInflammation management: Dexamethasone Sodium Phosphate helps reduce inflammation.\n\nLocal administration: Drops allow topical application when suitable for the diagnosed condition.\n\nSupport for prescribed treatment: May be included in a healthcare professional's treatment plan for selected eye or ear conditions.\n\nThis product is not suitable for every infection. Its effectiveness depends on the cause of the condition, bacterial susceptibility, correct administration, and adherence to the prescribed treatment.\n\nHow to Use CIPVISION ONLYAX DEXA Eye/Ear Drops\n\nUse CIPVISION ONLYAX DEXA according to your doctor's instructions and the product label.\n\nWash your hands: Clean your hands before handling the bottle or administering the drops.\n\nCheck the product: Confirm the product name, expiry date, and instructions before use.\n\nAvoid contamination: Do not allow the dropper tip to touch your eye, ear, fingers, or other surfaces.\n\nFollow the prescribed dose: Use only the number of drops and the frequency recommended by your healthcare professional.\n\nComplete the prescribed course: Do not stop, extend, or repeat treatment without medical advice.\n\nAvoid sharing: Never share the bottle with another person, as this can spread infection.\n\nStore correctly: Follow the storage and after-opening instructions printed on the packaging.\n\nFor eye administration, ask your healthcare professional about contact lens precautions. For ear administration, seek advice before use if you have had ear surgery, have ear tubes, or may have a perforated eardrum.\n\nPrecautions and Safety Information\n\nCIPVISION ONLYAX DEXA should be used only when clinically indicated. Its antibiotic and corticosteroid components may not be appropriate for every patient or type of infection.\n\nProlonged use: Extended or inappropriate corticosteroid use may increase eye pressure, contribute to glaucoma or cataracts, and delay tissue healing.\n\nInfection risks: Corticosteroids may mask symptoms or worsen certain viral, fungal, or untreated infections.\n\nAllergies: Inform your healthcare professional about any previous reaction to Ofloxacin, Dexamethasone, or related ingredients.\n\nExisting conditions: Disclose any history of glaucoma, eye disease, ear problems, or ear surgery before treatment.\n\nOther medicines: Tell your doctor about other prescription medicines and eye or ear preparations you are using.\n\nPregnancy and breastfeeding: Seek medical advice before using the product during pregnancy or while breastfeeding.\n\nWorsening symptoms: Obtain prompt medical assessment if symptoms persist, worsen, or return after treatment.\n\nSeek urgent medical attention for severe eye pain, sudden changes in vision, significant hearing changes, or other serious symptoms.\n\nDo not use the product after its expiry date. Follow the packaging instructions for storage and disposal after opening.\n\nWhy Is CIPVISION ONLYAX DEXA Relevant to Pharmaceutical Product Portfolios?\n\nCIPVISION ONLYAX DEXA combines two established pharmaceutical ingredients in a topical formulation intended for selected conditions involving bacterial infection and inflammation. Its defined composition and identifiable brand make it relevant to pharmaceutical catalogues and product information resources.\n\nFor pharmacies, distributors, healthcare professionals, and pharmaceutical websites, clear product information helps communicate the formulation's intended use, precautions, and administration requirements. Accurate product descriptions should always reflect the approved label rather than imply that the formulation is suitable for every eye or ear complaint.\n\nConclusion\n\nCIPVISION ONLYAX DEXA Eye/Ear Drops contains Ofloxacin and Dexamethasone Sodium Phosphate, combining antibacterial activity with anti-inflammatory action. It may be prescribed for selected eye or ear conditions when both components are clinically appropriate.\n\nUnderstanding the composition, intended applications, administration precautions, and potential risks supports responsible use. Always consult a qualified healthcare professional and refer to the approved product packaging for the exact strength, indications, contraindications, and directions for use.\n\nFrequently Asked Questions (FAQs)\n\n1. What is CIPVISION ONLYAX DEXA Eye/Ear Drops?\n\nCIPVISION ONLYAX DEXA is a pharmaceutical formulation containing Ofloxacin, an antibiotic, and Dexamethasone Sodium Phosphate, a corticosteroid. It is intended for selected conditions as directed by a healthcare professional.\n\n2. What is the composition of CIPVISION ONLYAX DEXA?\n\nThe stated active ingredients are Ofloxacin and Dexamethasone Sodium Phosphate. Refer to the product packaging to confirm their exact strengths and the approved formulation details.\n\n3. What is CIPVISION ONLYAX DEXA used for?\n\nIt may be prescribed for certain bacterial eye or ear conditions associated with inflammation when an antibiotic-corticosteroid combination is appropriate.\n\n4. Can CIPVISION ONLYAX DEXA be used without medical advice?\n\nNo. Medical guidance is important because the corticosteroid component may worsen certain infections or be unsuitable for particular eye and ear conditions.\n\n5. How should CIPVISION ONLYAX DEXA be stored?\n\nFollow the storage instructions printed on the product packaging. Keep the bottle tightly closed as directed, protect it from unsuitable storage conditions, and keep it out of children's reach.\n\n6. Can CIPVISION ONLYAX DEXA be used for every type of eye or ear infection?\n\nNo. Different infections and inflammatory conditions require different treatments. A healthcare professional should identify the cause of the symptoms and confirm whether this formulation is appropriate.",
"price": 50.0,
"discountamount": 15.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2502,
"imageuri": "https://productimages.withfloats.com/actual/6ad73887063777c0e22d5809.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6ad73887063777c0e22d5809.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-10-20T09:46:46.02Z",
"updatedon": "2026-10-20T09:46:46.02Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//ofloxacin-dexamethasoneone-sodium-phosphate-eye-ear-drops/2502",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "CIPVISION ONLYAX DEXA",
"category": "Opthalmology Range",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a9532d9dc13d720a47ea143",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tolperisone Hydrochloride Sustained Release Tablets 450 mg",
"description": "**Tolperisone hydrochloride** is a centrally acting muscle relaxant used to help reduce excessive muscle tone, stiffness, and muscle spasms associated with certain musculoskeletal and neurological conditions. Compared with some other centrally acting muscle relaxants, tolperisone is generally considered to have relatively limited sedative effects, although individual responses can vary.\n\n**TOPERITME 450** is formulated as a sustained-release tablet. This formulation is designed to release the active ingredient gradually, helping maintain its therapeutic effect over the prescribed dosing period.\n\nWhat TOPERITME 450 May Be Used For\n\nA healthcare professional may prescribe **TOPERITME 450** for conditions involving painful muscle tightness or spasms, including:\n\n* Painful muscle spasms\n* Selected musculoskeletal disorders\n* Neck and shoulder muscle stiffness\n* Lower back discomfort associated with muscle spasm\n* Cervical or lumbar spondylosis accompanied by muscle tightness\n* Muscle spasms associated with injury or trauma\n* Increased muscle tone associated with certain neurological conditions, when clinically appropriate\n\nThe decision to use tolperisone should be based on the patient's symptoms, diagnosis, and medical assessment.\n\nWhy TOPERITME 450 May Be Preferred\n\nTOPERITME 450 may offer several practical advantages when prescribed appropriately:\n\n* Sustained-release formulation for gradual drug delivery\n* Helps reduce muscle spasms and excessive muscle tension\n* May support improved movement when muscle stiffness is limiting mobility\n* Can help relieve discomfort associated with tight muscles\n* Convenient oral tablet formulation\n* Intended for use according to an individualized medical treatment plan\n\nPatients should always follow the dosage and duration recommended by their healthcare provider.\n\nMechanism of Action\n\n**Tolperisone hydrochloride** acts primarily through the central nervous system to reduce abnormal or excessive muscle activity. By modulating nerve signals involved in muscle tone and reflex activity, it can help decrease muscle stiffness and spasms.\n\nThe sustained-release formulation of **TOPERITME 450** is designed to release tolperisone progressively rather than all at once. This provides controlled delivery throughout the prescribed dosing interval.\n\n Dosage and Administration\n\nThe appropriate dose of **TOPERITME 450** should be determined by a qualified healthcare professional according to the patient's condition and treatment requirements.\n\nImportant administration instructions include:\n\n* Take the medicine exactly as prescribed.\n* Swallow the tablet whole with water.\n* Do not crush, chew, or split the sustained-release tablet unless specifically instructed by your doctor.\n* Maintain the prescribed dosing schedule.\n* If you forget a dose, seek guidance from your healthcare provider rather than taking an extra dose independently.\n\n Possible Side Effects\n\nSome individuals may experience side effects while taking **TOPERITME 450**. Potential reactions include:\n\n* Nausea\n* Dizziness\n* Headache\n* Weakness\n* Stomach discomfort\n* Allergic reactions\n\nNot everyone experiences side effects, and their severity can differ between individuals.\n\nIf serious allergic symptoms such as facial or throat swelling, breathing difficulty, or a severe unusual reaction occur, seek immediate medical attention.\n\nPrecautions to Discuss With Your Doctor\n\nBefore starting **TOPERITME 450**, inform your healthcare professional if you have:\n\n* Liver disease\n* Kidney disease\n* A previous history of drug allergies\n* Pregnancy or plans to become pregnant\n* Breastfeeding\n* Any other ongoing medical condition\n* Current use of prescription or over-the-counter medicines\n\nProviding a complete medication history can help your healthcare provider assess potential interactions and determine whether tolperisone is appropriate.\n\n Storage Guidelines\n\nFor proper storage of **TOPERITME 450**:\n\n* Keep the medicine in a cool and dry place.\n* Protect it from excessive moisture.\n* Keep the tablets away from direct sunlight.\n* Store according to the temperature instructions printed on the packaging.\n* Keep the medicine out of children's reach.\n* Do not use tablets after their stated expiry date.\n\nWhy Choose TOPERITME 450?\n\n**TOPERITME 450** contains tolperisone hydrochloride in a sustained-release formulation intended to provide controlled drug delivery. It may be selected by healthcare professionals for suitable patients experiencing muscle spasms, increased muscle tone, or stiffness associated with certain musculoskeletal conditions.\n\nTreatment should be individualized, and the medicine should be taken only according to professional medical advice.\n\n Frequently Asked Questions\n\nWhat is TOPERITME 450 prescribed for?\n\nTOPERITME 450 may be prescribed to help manage painful muscle spasms, stiffness, and increased muscle tone associated with selected musculoskeletal or neurological conditions.\n\nHow should I take TOPERITME 450?\n\nTake TOPERITME 450 exactly as prescribed and swallow the sustained-release tablet whole with water. Do not crush or chew it unless your healthcare professional specifically instructs you to do so.\n\nCan I stop TOPERITME 450 when my symptoms improve?\n\nDo not discontinue or modify your treatment without consulting your healthcare provider. The recommended treatment duration depends on your condition and individual response.\n\nIs TOPERITME 450 safe during pregnancy?\n\nUse during pregnancy should only be considered after consultation with a qualified healthcare professional, who can assess the potential benefits and risks for the individual patient.\n\nCan TOPERITME 450 cause drowsiness?\n\nSome individuals may experience dizziness or drowsiness, while others may not. If you experience impaired alertness, avoid driving or operating machinery until you know how the medicine affects you.",
"price": 530.0,
"discountamount": 159.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2500,
"imageuri": "https://productimages.withfloats.com/actual/6a9532dd5c122cfb47f3b8bb.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a9532dd5c122cfb47f3b8bb.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-31T07:52:57.389Z",
"updatedon": "2026-08-31T07:52:57.389Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tolperisone-hydrochloride-sustained-release-tablets-450-mg/2500",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TOPERITIME 450",
"category": "ORTHOPEDICS RANGE",
"tags": [
"Tolperisone Hydrochloride Sustained Release Tablets 450 mg",
"tolperisone hydrochloride uses",
"tolperisone hydrochloride",
"tolperisone hydrochloride use"
],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a7722af7f45a0190eb37920",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Tolperisone Hydrochloride & Paracetamol Tablets",
"description": "TOPERITIME P 150/325: Dual-Action Relief for Musculoskeletal Pain and Spasms\nTOPERITIME P 150/325 is a prescription combination therapy formulated to treat acute musculoskeletal discomfort, muscle stiffness, and associated inflammatory pain. By uniting a centrally acting muscle relaxant with a proven analgesic, this film-coated tablet addresses both the neurological and physical aspects of muscle strain, restoring movement and facilitating recovery.\n\nActive Ingredients\nEach film-coated tablet contains:\n\nTolperisone Hydrochloride (150 mg): A muscle relaxant targeting involuntary contractions within the central nervous system.\n\nParacetamol (325 mg): A widely recognized analgesic and antipyretic agent that blocks pain signal transmission.\n\nAvailable in blister packaging and dispensed strictly under a licensed physician's order.\n\nTherapeutic Mechanism\nPainful muscle conditions often create a feedback loop where localized pain triggers involuntary spasms, which in turn exacerbate the pain. TOPERITIME P 150/325 disrupts this cycle through a two-pronged mechanism:\n\nNeuromuscular Regulation: Tolperisone Hydrochloride acts on the spinal cord and brainstem reflexes to inhibit hyperactive nerve impulses driving muscle tension. Unlike traditional skeletal muscle relaxants, it achieves this with minimal central nervous system depression, significantly reducing the likelihood of heavy sedation.\n\nNociceptive Blocking: Paracetamol inhibits prostaglandin synthesis within the central nervous system, raising the body's overall pain threshold and attenuating pain signals originating from injured tissues.\n\nBy simultaneously relaxing tight muscle fibers and dampening pain sensation, the formulation provides comprehensive symptomatic relief.\n\nClinical Indications\nHealthcare professionals may prescribe TOPERITIME P 150/325 for various acute and subacute conditions characterized by pain and hypertonia, including:\n\nAcute muscle spasms and athletic injuries\n\nAcute or chronic lower back pain (lumbago)\n\nCervical spine discomfort and stiff neck\n\nCervical and lumbar spondylosis\n\nFrozen shoulder (adhesive capsulitis)\n\nPost-operative or post-traumatic muscle recovery\n\nGeneralized connective tissue or orthopedic pain\n\nKey Clinical Features\nBalanced Dual Action: Simultaneously targets involuntary contractions and pain sensation.\n\nLow-Sedation Profile: Tolperisone allows patients to maintain daily function without severe daytime drowsiness typical of older relaxants.\n\nEnhanced Mobility: Reduces joint and tissue stiffness, enabling better engagement in physical rehabilitation.\n\nStreamlined Regimen: Combines two therapeutic agents into a single convenient dosage form.\n\nUsage Guidelines\nThis medication must be taken strictly in accordance with a medical prescription.\n\nAdministration: Swallow the tablet whole with water. Do not crush, chew, or split the film-coated tablet.\n\nTiming: Take immediately after a meal to reduce potential gastrointestinal upset, unless directed otherwise by a doctor.\n\nCompliance: Complete the full course prescribed by your physician, and do not alter the recommended dosage.\n\nPotential Side Effects\nWhile generally well-tolerated, some individuals may experience mild side effects, including:\n\nGastrointestinal distress or mild nausea\n\nTransient dizziness or lightheadedness\n\nHeadaches\n\nGeneral fatigue or muscular weakness\n\nRare: Hypersensitivity reactions or cutaneous skin rashes (discontinue use and consult a physician immediately if severe symptoms appear).\n\nSafety Precautions and Considerations\nConsult a medical practitioner prior to initiating treatment if any of the following apply:\n\nPre-existing hepatic (liver) or renal (kidney) impairment\n\nKnown hypersensitivity to Tolperisone, Paracetamol, or related compounds\n\nPregnancy, plans for pregnancy, or active breastfeeding\n\nHistory of chronic alcohol dependency (due to increased liver sensitivity with Paracetamol)\n\nConcurrent use of other medications, particularly other products containing Paracetamol or central nervous system depressants\n\nStorage and Handling\nStore in a cool, dry area below 25°C (77°F).\n\nProtect from direct light, heat, and moisture.\n\nKeep strictly out of reach of children and pets.\n\nCheck the packaging expiration date before administration.\n\nFrequently Asked Questions\nWhat primary conditions does TOPERITIME P 150/325 treat?\n\nIt is indicated for short-term relief from acute musculoskeletal pain, muscle spasms, neck strains, backaches, and related orthopedic disorders.\n\nWhy is Tolperisone combined with Paracetamol?\n\nTolperisone eases muscle tightness at the neurological level, while Paracetamol lowers overall pain perception, creating a synergistic effect that addresses both spasm and pain together.\n\nWill this medication cause severe drowsiness?\n\nTolperisone is specifically designed to exert less sedating activity compared to older muscle relaxants. However, individual sensitivity varies, so caution is advised when driving or operating machinery until individual tolerance is established.\n\nIs TOPERITIME P 150/325 available over the counter?\n\nNo. It requires a valid medical prescription and direct supervision by a registered healthcare professional.",
"price": 95.0,
"discountamount": 29.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2493,
"imageuri": "https://productimages.withfloats.com/actual/6a7722b0ed25653efa18364e.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a7722b0ed25653efa18364e.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-08T12:35:59.075Z",
"updatedon": "2026-08-08T12:35:59.075Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//tolperisone-hydrochloride-paracetamol-tablets/2493",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "TOPERITIME P 150/325",
"category": "ORTHOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6def248b0777b5cb29791c",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Propranolol Hydrochloride Sustained Release Capsules IP",
"description": "PROPASULES LA 40 is a premium pharmaceutical formulation containing Propranolol Hydrochloride Sustained Release Capsules IP 40 mg. Developed with advanced sustained-release technology, this formulation delivers the active ingredient gradually over an extended period, helping maintain consistent therapeutic levels while supporting the convenience of once-daily administration when prescribed by a healthcare professional.\n\nManufactured in GMP-certified facilities using pharmaceutical-grade raw materials, PROPASULES LA 40 is produced under strict quality control measures to ensure purity, safety, and batch-to-batch consistency. It is intended for the treatment of medical conditions in which propranolol therapy is considered appropriate by a qualified physician.\n\nComposition\n\nEach Sustained Release Capsule Contains:\n\nPropranolol Hydrochloride IP – 40 mg\nSustained Release Pellets\nPharmaceutical Excipients – q.s.\nCapsule Shell – Approved pharmaceutical-grade ingredients\n\nDosage Form: Sustained Release Capsules\n\nWhat is PROPASULES LA 40?\n\nPROPASULES LA 40 contains Propranolol Hydrochloride, a non-selective beta-adrenergic receptor blocker (beta-blocker) that helps manage a variety of cardiovascular and neurological conditions. The sustained-release formulation is specifically designed to release the medicine gradually throughout the day, providing prolonged therapeutic action and helping maintain stable plasma drug concentrations compared with conventional immediate-release formulations.\n\nIts controlled-release technology enhances dosing convenience and supports consistent treatment outcomes when used according to medical advice.\n\nKey Features\nContains Propranolol Hydrochloride Sustained Release IP 40 mg\nAdvanced sustained-release technology for prolonged drug delivery\nSupports once-daily dosing as prescribed\nManufactured using premium pharmaceutical-grade ingredients\nProduced in GMP-compliant manufacturing facilities\nStringent quality assurance for consistent product performance\nReliable formulation for long-term therapeutic use under medical supervision\nTherapeutic Uses\n\nHealthcare professionals may prescribe PROPASULES LA 40 for the management of several cardiovascular and neurological disorders, including:\n\nHypertension (high blood pressure)\nChronic stable angina\nCardiac arrhythmias\nPrevention of migraine attacks\nEssential tremor\nPhysical symptoms associated with anxiety\nCardiovascular manifestations of hyperthyroidism\nSecondary prevention following myocardial infarction, when clinically indicated\n\nThe choice of treatment, dosage, and duration should always be individualized based on the patient's medical condition and physician's assessment.\n\nHow PROPASULES LA 40 Works\n\nPropranolol Hydrochloride works by blocking beta-adrenergic receptors located in the heart and other tissues. This action reduces the effects of adrenaline and other stress hormones on the cardiovascular system.\n\nAs a result, the medicine may help:\n\nSlow the heart rate\nReduce the workload on the heart\nLower elevated blood pressure\nImprove control of certain abnormal heart rhythms\nReduce the frequency of migraine episodes\nMinimize symptoms associated with essential tremor\nRelieve physical manifestations of anxiety, such as rapid heartbeat and trembling\n\nThe sustained-release pellets gradually release the medication throughout the day, providing prolonged therapeutic coverage and reducing fluctuations in drug levels.\n\nBenefits of the Sustained Release Formulation\n\nThe advanced sustained-release technology offers several advantages:\n\nControlled and gradual release of the active ingredient\nExtended therapeutic effect throughout the dosing interval\nMore consistent blood concentrations of the medication\nReduced peak-to-trough fluctuations compared with immediate-release formulations\nConvenient dosing schedule that may improve treatment adherence\nSuitable for long-term therapy under medical supervision\n\nTreatment outcomes depend on individual patient response and adherence to the prescribed regimen.\n\nDosage and Administration\n\nTake PROPASULES LA 40 exactly as instructed by your healthcare provider.\n\nGeneral recommendations include:\n\nSwallow the capsule whole with sufficient water.\nDo not crush, chew, or open the capsule unless specifically advised.\nTake the medicine at the same time every day.\nFollow the prescribed dosage schedule carefully.\nDo not discontinue treatment abruptly without consulting your physician, as sudden withdrawal may increase the risk of cardiovascular complications.\nPossible Side Effects\n\nLike all medications, PROPASULES LA 40 may cause side effects in some individuals, although many patients tolerate it well.\n\nCommon side effects may include:\n\nFatigue\nDizziness\nSlow heartbeat\nCold hands and feet\nNausea\nSleep disturbances\nMild stomach discomfort\n\nSeek immediate medical attention if you experience breathing difficulty, severe dizziness, fainting, swelling of the face or throat, or signs of a serious allergic reaction.\n\nConsult your healthcare provider if any side effects persist or become troublesome.\n\nPrecautions and Warnings\n\nBefore starting PROPASULES LA 40, inform your doctor if you have:\n\nAsthma or chronic obstructive pulmonary disease (COPD)\nDiabetes mellitus\nLiver impairment\nKidney disease\nHeart failure\nLow blood pressure\nBradycardia (slow heart rate)\nPeripheral vascular disease\nThyroid disorders\nHistory of hypersensitivity reactions\n\nYour physician should also be informed about all prescription medicines, over-the-counter drugs, herbal supplements, and dietary products you are taking to minimize the risk of drug interactions.\n\nPregnancy and Breastfeeding\n\nThe use of PROPASULES LA 40 during pregnancy or breastfeeding should only be considered when recommended by a qualified healthcare professional after carefully evaluating the potential benefits and possible risks.\n\nAlways consult your physician before taking this medicine during pregnancy or while nursing.\n\nStorage Instructions\n\nTo maintain product quality:\n\nStore in a cool and dry place.\nProtect from moisture and direct sunlight.\nKeep below the storage temperature specified on the product label.\nStore in the original packaging until use.\nKeep out of the reach of children.\nDo not use the medicine after the expiry date printed on the pack.\nWhy Choose PROPASULES LA 40?\n\nPROPASULES LA 40 is formulated to deliver dependable therapeutic performance through advanced sustained-release technology. Manufactured under stringent pharmaceutical quality standards, it combines consistent drug delivery, convenient dosing, and reliable product quality to support long-term cardiovascular and neurological care.\n\nKey Advantages\n\nPremium sustained-release Propranolol formulation\nControlled drug release for prolonged therapeutic action\nConvenient once-daily administration as prescribed\nManufactured in GMP-certified facilities\nHigh standards of quality, purity, and consistency\nReliable formulation for chronic disease management\nFrequently Asked Questions (FAQs)\nWhat is PROPASULES LA 40 prescribed for?\n\nPROPASULES LA 40 may be prescribed for conditions such as hypertension, chronic angina, cardiac arrhythmias, migraine prevention, essential tremor, anxiety-related physical symptoms, and certain cardiovascular conditions, depending on the physician's evaluation.\n\nCan PROPASULES LA 40 be taken once a day?\n\nYes. The sustained-release formulation is designed to support convenient once-daily dosing when prescribed by a healthcare professional.\n\nCan I stop taking PROPASULES LA 40 suddenly?\n\nNo. Abrupt discontinuation of propranolol may increase the risk of serious cardiovascular events. Always consult your doctor before stopping treatment.\n\nCan people with diabetes take PROPASULES LA 40?\n\nPatients with diabetes should use this medicine only under medical supervision, as beta-blockers may mask some warning signs of low blood sugar.\n\nIs PROPASULES LA 40 suitable for every patient?\n\nNo. This medicine may not be appropriate for individuals with certain conditions such as severe asthma, significant bradycardia, or specific cardiac disorders. Your healthcare provider will determine whether it is suitable for your individual medical needs.",
"price": 45.0,
"discountamount": 14.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2490,
"imageuri": "https://productimages.withfloats.com/actual/6a6def271f223d84dee2d962.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6def271f223d84dee2d962.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T13:05:40.676Z",
"updatedon": "2026-08-01T13:05:40.676Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//propranolol-hydrochloride-sustained-release-capsules-ip/2490",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "PROPASULES LA 40",
"category": "CARDIOLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a6dedd85b0d81b5d5e65e09",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Olanzapine Mouth Dissolving Tablets 2.5 mg",
"description": "OLANZPRIME 2.5 is a high-quality pharmaceutical formulation containing Olanzapine 2.5 mg in a convenient mouth dissolving tablet (MDT) dosage form. Developed to support the management of various psychiatric disorders, this formulation is designed to deliver effective therapy while improving patient convenience and treatment adherence. Manufactured in GMP-certified facilities using premium pharmaceutical ingredients, OLANZPRIME 2.5 is produced under strict quality control standards to ensure safety, purity, and consistent performance.\n\nThe rapidly dissolving tablet is formulated to disintegrate quickly on the tongue without the need for water, making it an ideal option for patients who have difficulty swallowing conventional tablets. Its user-friendly dosage form enhances ease of administration while providing dependable therapeutic support under the supervision of a qualified healthcare professional.\n\nComposition\n\nBrand Name: OLANZPRIME 2.5\n\nGeneric Name: Olanzapine\n\nStrength: 2.5 mg\n\nDosage Form: Mouth Dissolving Tablet (MDT)\n\nWhat is OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 contains Olanzapine, an atypical antipsychotic medication that works by regulating the activity of important neurotransmitters such as dopamine and serotonin. By helping restore the balance of these chemical messengers, the medicine supports improved emotional stability, clearer thinking, better behavioral control, and overall mental health.\n\nIts mouth dissolving formulation is specifically designed to provide greater convenience, particularly for individuals who experience difficulty swallowing standard oral tablets.\n\nUses of OLANZPRIME 2.5\n\nOLANZPRIME 2.5 may be recommended by healthcare professionals for the treatment and long-term management of various psychiatric conditions, including:\n\nSchizophrenia\nBipolar disorder, including manic and mixed episodes\nMaintenance therapy for bipolar disorder\nManagement of psychotic symptoms\nSelected behavioral or psychiatric conditions as determined by a physician\n\nThe appropriate dosage and duration of therapy should always be decided by a qualified healthcare provider based on the patient's individual clinical needs.\n\nBenefits of OLANZPRIME 2.5\nQuick-Dissolving Technology\n\nThe tablet dissolves rapidly in the mouth without requiring water, making administration simple and convenient.\n\nImproved Patient Adherence\n\nThe easy-to-take formulation is especially beneficial for elderly patients and individuals with swallowing difficulties, helping improve compliance with prescribed treatment.\n\nProven Antipsychotic Therapy\n\nOlanzapine is a well-established atypical antipsychotic used by healthcare professionals to help manage symptoms associated with schizophrenia and bipolar disorder.\n\nManufactured to High Pharmaceutical Standards\n\nProduced under strict GMP guidelines, OLANZPRIME 2.5 undergoes comprehensive quality testing to ensure consistent safety, efficacy, and product reliability.\n\nConvenient Anytime Administration\n\nThe mouth dissolving dosage form offers flexibility and ease of use, even when drinking water is not readily available.\n\nHow OLANZPRIME 2.5 Works\n\nOlanzapine belongs to the atypical antipsychotic class of medicines. It acts by modulating the activity of dopamine and serotonin receptors in the brain, helping restore a healthy balance of neurotransmitters involved in mood, perception, and behavior.\n\nThis therapeutic action may help reduce symptoms such as:\n\nHallucinations\nDelusional thoughts\nAgitation\nMood fluctuations\nDisorganized thinking\nAnxiety associated with certain psychiatric conditions\n\nWith regular use as prescribed, OLANZPRIME 2.5 helps support mental stability and improves overall quality of life for many patients.\n\nDosage and Administration\n\nTake OLANZPRIME 2.5 exactly as directed by your healthcare professional.\n\nGeneral administration guidelines include:\n\nPlace the tablet directly on the tongue.\nAllow it to dissolve completely before swallowing.\nWater is generally not required.\nTake the medication at the same time each day whenever possible.\nContinue treatment for the duration recommended by your physician.\nDo not stop taking the medicine without medical advice.\nPossible Side Effects\n\nLike all prescription medicines, OLANZPRIME 2.5 may cause side effects in some individuals, although not everyone experiences them.\n\nCommon side effects may include:\n\nDrowsiness\nDizziness\nDry mouth\nIncreased appetite\nWeight gain\nConstipation\nTiredness\n\nSerious or unusual symptoms require prompt medical evaluation. Always consult your healthcare provider if side effects become persistent or concerning.\n\nPrecautions and Warnings\n\nBefore starting OLANZPRIME 2.5, inform your healthcare provider if you have:\n\nDiabetes mellitus\nLiver disorders\nHeart disease\nEpilepsy or seizure disorders\nHigh cholesterol or lipid abnormalities\nHistory of stroke\nKidney impairment\nKnown allergy to Olanzapine or any ingredient in the formulation\n\nAlcohol consumption should generally be avoided during treatment, as it may increase drowsiness and other central nervous system effects.\n\nStorage Instructions\n\nTo preserve product quality:\n\nStore in a cool and dry place.\nProtect from direct sunlight and excessive moisture.\nKeep below the storage temperature mentioned on the product packaging.\nStore in the original blister pack until use.\nKeep out of the reach of children.\nWhy Choose OLANZPRIME 2.5?\n\nOLANZPRIME 2.5 combines trusted antipsychotic therapy with the convenience of mouth dissolving technology, making it an excellent option for patients who require easy administration without compromising treatment effectiveness.\n\nKey Advantages\n\nPremium-quality Olanzapine 2.5 mg formulation\nRapid mouth dissolving tablet for easy administration\nNo water required for consumption\nSupports improved medication compliance\nManufactured under stringent GMP quality standards\nReliable dosage accuracy and product consistency\nSecure packaging designed to maintain product stability\nFrequently Asked Questions (FAQs)\nWhat is OLANZPRIME 2.5 prescribed for?\n\nOLANZPRIME 2.5 is prescribed for the treatment and management of schizophrenia, bipolar disorder, and other psychiatric conditions as determined by a qualified healthcare professional.\n\nDoes this tablet need to be taken with water?\n\nNo. The mouth dissolving tablet is designed to dissolve on the tongue, allowing convenient administration without water.\n\nCan I discontinue OLANZPRIME 2.5 without consulting my doctor?\n\nNo. Treatment should not be stopped suddenly, as abrupt discontinuation may increase the risk of symptom recurrence or withdrawal effects. Always seek medical advice before making any changes to your medication.\n\nIs OLANZPRIME 2.5 appropriate for older adults?\n\nHealthcare professionals may prescribe this medicine for elderly patients when clinically appropriate. Individual dosage adjustments may be necessary depending on the patient's overall health and medical history.\n\nHow long should treatment continue?\n\nThe duration of therapy varies according to the patient's diagnosis, treatment response, and clinical condition. Your healthcare provider will determine the most appropriate treatment plan and monitor progress throughout therapy.",
"price": 60.0,
"discountamount": 18.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2489,
"imageuri": "https://productimages.withfloats.com/actual/6a6deddbc0246085c8f7252b.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a6deddbc0246085c8f7252b.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-08-01T13:00:08.65Z",
"updatedon": "2026-08-01T13:00:08.65Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-2-5-mg/2489",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "OLANZPRIME 2.5",
"category": "NEUROLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
},
{
"_id": "6a5df5b80932adf55b8b989e",
"fptag": "STERISHEALTHCARE",
"merchantname": null,
"customwidgets": null,
"externalsourceid": null,
"name": "Olanzapine Mouth Dissolving Tablets 15 mg",
"description": "OLANZPRIME 15 is a mouth-dissolving tablet containing Olanzapine 15 mg, prescribed for schizophrenia and bipolar disorder. As an atypical antipsychotic, it works by rebalancing dopamine and serotonin activity in the brain, easing hallucinations, delusions, mood swings, and disorganized thinking. The dissolving format is built for patients who find swallowing standard tablets difficult, letting the tablet break down on the tongue without water. It's typically taken once daily at a consistent time, under a psychiatrist's supervision, and should never be stopped abruptly. Common effects include drowsiness and appetite changes. Prescription only – consult your doctor.\n\nMeta Title Options (50–60 characters)\nOLANZPRIME 15 Price – Olanzapine MD Tablet | Steris (Recommended)\nOLANZPRIME 15 – Olanzapine Mouth Dissolving Tablet\nOLANZPRIME 15 Price – Schizophrenia & Bipolar Care\nOlanzapine 15mg MD Tablet – OLANZPRIME Price\nOLANZPRIME 15 – Antipsychotic MD Tablet Online\n\nRationale: Option 1 leads with the required “Price” anchor for this Schedule H product, keeps the brand and dosage form searchable, and stays within the 50–60 character target.\n\nMeta Description (140–160 characters)\n\nOLANZPRIME 15 (Olanzapine 15mg MD) eases schizophrenia and bipolar symptoms. Check price online. Prescription only – consult your doctor before use.\n\nFull CMS Article\nOLANZPRIME 15: Olanzapine Mouth Dissolving Tablet for Schizophrenia and Bipolar Disorder\nTL;DR / AI Mode Summary\n\nOLANZPRIME 15 delivers Olanzapine 15 mg in a mouth-dissolving format, used in the treatment of schizophrenia and bipolar disorder. It belongs to the atypical antipsychotic class and acts on dopamine and serotonin pathways to ease hallucinations, delusions, mood instability, and disorganized thought. The dissolving tablet is especially useful for patients — including elderly or psychiatric patients — who struggle with swallowing regular pills. It is a Schedule H medicine and must be taken strictly as prescribed by a psychiatrist.\n\nWhat Is OLANZPRIME 15?\n\nOLANZPRIME 15 is built around Olanzapine, a second-generation (atypical) antipsychotic that psychiatrists prescribe to manage serious mental health conditions. Rather than a standard swallow-with-water tablet, this formulation is designed to break down on the tongue within seconds, which supports better adherence in patients who find conventional dosing forms hard to manage.\n\nComposition at a Glance\nAttribute\tDetail\nBrand Name\tOLANZPRIME 15\nActive Ingredient\tOlanzapine\nStrength\t15 mg\nForm\tMouth Dissolving Tablet (MD)\nTherapeutic Class\tAtypical Antipsychotic\nSchedule Status\tSchedule H – Prescription Only\nCommon Indications\nSchizophrenia\nBipolar I Disorder, including manic episodes\nLong-term maintenance therapy for bipolar disorder\nAcute agitation linked to psychotic episodes, under physician direction\nMood instability requiring antipsychotic support\nOther psychiatric conditions where antipsychotic therapy is indicated\n\nBy calming excess dopamine signaling, this medicine can reduce hallucinations, delusional thinking, and aggression, helping patients function more steadily day to day.\n\nMechanism of Action\n\nPsychiatric symptoms such as hallucinations, delusions, and racing or disorganized thoughts are closely tied to overactive dopamine (D2) signaling in the brain, alongside disruptions in serotonin (5-HT2A) pathways.\n\nOlanzapine works by:\n\nDampening excess dopamine receptor activity\nModulating serotonin receptor signaling\nReducing hallucinations and delusional thought patterns\nSupporting emotional and mood stability\nEasing agitation and aggressive behavior\nImproving focus and social engagement\nSupporting more restful sleep\n\nBecause the tablet dissolves directly in the mouth, it's absorbed without needing water, making it a practical option for elderly patients and those with swallowing difficulty.\n\nDirections for Use\nTake OLANZPRIME 15 only as your psychiatrist prescribes.\nPlace the tablet on the tongue and let it dissolve fully — do not chew.\nSwallow naturally once dissolved; water is generally not needed.\nTake it at the same time each day to build a consistent routine.\nNever stop the medicine abruptly without medical guidance, as sudden discontinuation can trigger withdrawal or relapse symptoms.\nPossible Side Effects\n\nMost side effects are mild and tend to ease as the body adjusts. These can include:\n\nDrowsiness\nDizziness\nIncreased appetite\nWeight gain\nDry mouth\nConstipation\nFatigue\nTremors\nRestlessness\n\nPlaceholder: incidence rates and comparative trial data pending qualified clinical reviewer sign-off before publication.\n\nGet emergency medical help if you experience a severe allergic reaction, uncontrollable muscle movements, high fever, confusion, or trouble breathing — these may indicate a rare but serious reaction.\n\nWho Should Be Cautious\n\nTell your doctor before starting OLANZPRIME 15 if you have:\n\nDiabetes\nLiver or kidney disease\nHeart conditions\nEpilepsy or seizure history\nHigh cholesterol\nObesity\nGlaucoma\nDementia\nA history of stroke\n\nAvoid alcohol during treatment, as it can intensify drowsiness. Pregnant or breastfeeding women should use this medicine only under close medical supervision, weighing benefits against risks with their doctor.\n\nPrecautions & Storage\nTake exactly as prescribed — never adjust the dose on your own.\nWatch for changes in weight, appetite, or blood sugar during long-term use, and report these to your doctor.\nDon't combine with alcohol or other sedating substances without medical advice.\nStore below 25°C, away from moisture and direct sunlight.\nKeep in the original packaging, out of reach of children.\nComparable Antipsychotic Options\nMedicine Type\tTypical Use Case\tDosage Form Convenience\nStandard Olanzapine Tablets\tSchizophrenia, bipolar disorder\tRequires water to swallow\nOLANZPRIME 15 (MD Tablet)\tSame indications, for patients with swallowing difficulty\tDissolves on tongue, no water needed\nOther Atypical Antipsychotics\tAlternate receptor profiles, physician's choice\tVaries by brand and formulation\n\nNote: Switching between antipsychotic medicines or formulations should only be done under a psychiatrist's guidance.\n\nWhy Choose OLANZPRIME 15?\n\nBeyond its therapeutic role in managing schizophrenia and bipolar disorder, OLANZPRIME 15's mouth-dissolving format addresses a real, practical barrier many psychiatric patients face — reliably swallowing tablets every day. Manufactured to consistent quality standards, it gives psychiatrists a dependable option for patients who need both clinical effectiveness and easier day-to-day administration.\n\nConclusion\n\nLiving with schizophrenia or bipolar disorder often means managing symptoms that affect mood, thought, and daily functioning. OLANZPRIME 15 is formulated to help rebalance the brain chemistry behind these symptoms, in a mouth-dissolving form that simplifies daily dosing for patients who struggle with conventional tablets. Used consistently and under a psychiatrist's care, it supports more stable, manageable day-to-day life. Prescription only – consult your doctor.\n\nFrequently Asked Questions\nWhat is OLANZPRIME 15 used for? It's prescribed for schizophrenia, bipolar disorder, and related psychiatric conditions, under a doctor's guidance.\nHow should I take OLANZPRIME 15? Place it on your tongue, let it dissolve fully, and swallow naturally — follow your doctor's exact dosing instructions.\nDo I need water to take it? No, as a mouth-dissolving tablet it typically doesn't require water.\nCan it cause weight gain? Yes, increased appetite and weight gain are recognized effects in some patients; your doctor may recommend periodic monitoring.\nIs it safe for long-term use? Yes, under a psychiatrist's ongoing supervision with regular follow-up to track effectiveness and side effects.\nCan I stop taking it once I feel better? No — stopping suddenly can cause withdrawal effects or symptom relapse. Any change in dose must go through your doctor.\nDoes OLANZPRIME 15 interact with alcohol? Yes, alcohol can worsen drowsiness and should generally be avoided during treatment.\nIs it safe during pregnancy? It should only be used in pregnancy or breastfeeding under close medical supervision, after discussing risks and benefits with a doctor.\nWhat conditions should I disclose to my doctor before starting? Mention any history of diabetes, liver or kidney disease, heart conditions, epilepsy, high cholesterol, glaucoma, dementia, or stroke.\nCan this medicine affect blood sugar or cholesterol? It can, in some patients, which is why regular monitoring is often recommended during treatment.\nWhat should I do if I notice uncontrollable muscle movements? Seek immediate medical attention, as this can indicate a rare but serious reaction requiring urgent evaluation.\nCan elderly patients take OLANZPRIME 15? Yes, and the mouth-dissolving format is often specifically helpful for elderly patients with swallowing difficulty, but dosing should be carefully individualized by the prescriber.\nHow long does it take to see improvement? Response times vary by individual and condition; your psychiatrist will assess progress over scheduled follow-ups.\nCan OLANZPRIME 15 be taken with other psychiatric medicines? Only under medical supervision, as combinations need careful evaluation for interactions.\nIs a prescription required to purchase OLANZPRIME 15? Yes, it is a Schedule H medicine and can only be dispensed against a valid doctor's prescription.",
"price": 180.0,
"discountamount": 54.0,
"currencycode": "INR",
"priority": 1000000,
"isfreeshipmentavailable": false,
"shipmentduration": 1,
"_keywords": null,
"isarchived": false,
"isavailable": true,
"applicationid": null,
"productindex": 2478,
"imageuri": "https://productimages.withfloats.com/actual/6a5df5ba3a3f53b9d65c6aa2.png",
"tileimageuri": "https://productimages.withfloats.com/tile/6a5df5ba3a3f53b9d65c6aa2.png",
"images": null,
"totalqueries": 0,
"gpid": null,
"groupproductid": null,
"createdon": "2026-07-20T10:17:28.721Z",
"updatedon": "2026-07-20T10:24:54.243Z",
"buyonlinelink": null,
"producturl": "http://WWW.STERISINDIA.COM//olanzapine-mouth-dissolving-tablets-15-mg/2478",
"availableunits": -1.0,
"iscodavailable": false,
"isprepaidonlineavailable": false,
"maxcodorders": 0,
"maxprepaidonlineorders": 0,
"uniquepaymenturl": null,
"brandname": "OLANZPRIME 15",
"category": "NEUROLOGYRANGE",
"tags": [],
"variants": false,
"keyspecification": null,
"otherspecifications": null,
"pickupaddressreferenceid": null,
"paymenttype": "UniquePaymentUrl",
"producttype": "products",
"hsncode": null,
"gstslab": 0.0,
"isnotforsale": false
}
],
"hasmoreitems": false,
"isapirequest": false,
"totalresults": 27,
"query": null,
"floatingpoint": null
}